# Contact Iron Peptide Innovations — Editorial Digest

> Reach the Iron Peptide Innovations editorial team regarding citations, corrections, or research-related correspondence about our Recovery & Tissue Repair peptide digest.

Correspondence on citations, corrections, and research-related inquiries — the things a literature digest most wants to hear about.

## Editorial correspondence

Iron Peptide Innovations welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study about BPC-157 or TB-500 that should be added to the [references page](/references). Corrections that improve accuracy are the most useful messages received and are read carefully.

The most actionable notes specify three things: the page in question, the exact passage, and the supporting citation — a DOI or PubMed ID wherever possible. That lets any proposed change be verified against the source quickly.

**Editorial mailbox:** editors@ironpeptideinnovations.com

## What this digest cannot do

Iron Peptide Innovations is a literature digest, not a clinic or a vendor, so it cannot:

- Advise on, recommend, or comment on human use of any peptide discussed here.
- Suggest a dose, schedule, or route of administration for any individual.
- Diagnose a condition or judge whether a particular research finding applies to a particular person.
- Sell, source, recommend, or help locate any compound from any supplier.
- Answer requests from athletes subject to anti-doping rules about using these compounds, given that both are WADA-prohibited.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.

---

Peer-reviewed literature, summarized. Not a product, not a prescription, not a clinic.